| Financial Year |
March 31 2023 |
| Monetary Funds |
961,739,833.78 |
| Held-for-trading Financial Assets |
576,439,767.13 |
| Notes Receivable |
1,000,000.00 |
| Accounts Receivable |
31,516,787.48 |
| Advances to Suppliers |
3,253,073.17 |
| Other Receivables |
148,235,649.04 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
364,155,419.24 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,019,056.44 |
| Total Current Assets |
2,100,359,586.28 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
89,412,832.41 |
| Investment Properties |
477,847,501.88 |
| Fixed Assetes |
149,154,095.51 |
| Under-construction Projects |
23,414,135.41 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
24,351,182.58 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
17,097,684.37 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,818,710,804.10 |
| Total Assets |
3,919,070,390.38 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
451,086,669.47 |
| Accounts Received In Advance |
3,954,013.66 |
| Employee Compensation Payable |
64,072,878.15 |
| Taxes Payable |
4,009,562.97 |
| Interest Payable |
-- |
| Dividend Payable |
916,314.66 |
| Other payables |
94,909,447.99 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
41,459,181.72 |
| Other Current Liabilities |
41,474,888.90 |
| Sub-Total of Current Liabilities |
1,228,075,894.77 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
57,832,719.60 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
187,718,804.83 |
| Total Liabilities |
1,415,794,699.60 |
| Paid-In Capital(Or Share Stock) |
1,044,887,850.00 |
| Capital Surplus |
556,435,765.49 |
| Surplus Reserve |
194,508,982.75 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
536,218,570.17 |
| Minority Stockholder's Interest |
91,384.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,503,184,306.76 |
| Owner's Equity（Stockholder's Equity） |
2,503,275,690.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,919,070,390.38 |
